{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-032119","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2025-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.485874+00:00","generated_at":"2026-05-23T14:46:37.384950+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aditxt secures call option to purchase $25M Evofem convertible notes for $13M","bullets":["Aditxt granted call option to acquire Evofem convertible notes (aggregate $25M principal) and purchase rights from Adjuvant funds for $13M.","Option exercisable after Future Pak Note fully repaid, until June 30, 2025; exercise triggers $13M payment.","If Aditxt does not provide $1.5M capital to Evofem by April 30, 2025, Adjuvant may transfer securities without consent.","Evofem consents to assignment of notes and waives opinion of counsel requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-032119","json":"https://secwatch.observer/filing/0001213900-25-032119.json","markdown":"https://secwatch.observer/filing/0001213900-25-032119.md","text":"https://secwatch.observer/filing/0001213900-25-032119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/0001213900-25-032119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390025032119/ea0238436-8k_aditxt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T14:46:37.384950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}